Severe SARS-CoV-2 and respiratory syncytial virus co-infection in two children

Andreana Angelova1, Mariya Atanasova1, Kostadin Ketev1

  • 1Medical University of Plovdiv, Plovdiv, Bulgaria.

Folia Medica
|February 14, 2024
PubMed

Insights

Severe COVID-19 in children is rare but possible, especially with coinfections like respiratory syncytial virus. Early diagnosis with multiplex PCR is crucial for managing pediatric cases and preventing spread.

Area of Science:

  • Pediatrics
  • Infectious Diseases
  • Virology

Background:

  • Coronavirus Disease 2019 (COVID-19), caused by SARS-CoV-2, primarily impacts older adults.
  • Children typically experience milder COVID-19 symptoms, with severe cases being infrequent.
  • Comorbidities increase the risk of severe COVID-19 and mortality in adults.

Purpose of the Study:

  • To highlight the potential for severe COVID-19 in pediatric patients.
  • To emphasize the possibility of coinfections, such as with respiratory syncytial virus (RSV), leading to severe illness in children.
  • To underscore the importance of accurate and timely diagnosis in managing pediatric COVID-19 cases.

Main Methods:

  • Case report of two pediatric patients with severe COVID-19.
  • Utilized multiplex PCR for microbiological diagnosis.
  • Implemented contact precautions based on diagnostic results.

Main Results:

  • Identified coinfection with SARS-CoV-2 and RSV in two children presenting with severe COVID-19.
  • Multiplex PCR enabled early and accurate diagnosis.
  • Diagnostic findings facilitated prompt implementation of infection control measures.

Conclusions:

  • Coinfection can significantly influence the clinical course and outcome of pediatric COVID-19.
  • Multiplex PCR is a valuable tool for diagnosing viral coinfections in children.
  • Further research is needed to understand the impact of coinfections on pediatric COVID-19 severity.

Related Concept Videos

Acute Respiratory Failure-II01:21

Acute Respiratory Failure-II

Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
234
Common Respiratory Disorders01:31

Common Respiratory Disorders

Respiratory disorders, a prevalent health concern globally, are generally divided into two primary categories: upper and lower respiratory tract disorders. The categorization is based on the area of the respiratory system they affect.
Upper respiratory disorders impact the airways above the vocal cords, encompassing areas like the nose, sinuses, and throat. Various conditions fall under this category, including the common cold and allergic rhinitis. These disorders can stem from several causes,...
515
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
272
Acute Respiratory Failure-I01:21

Acute Respiratory Failure-I

Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
208
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
139
Acute Respiratory Failure-III01:30

Acute Respiratory Failure-III

Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
186